热门资讯> 正文
PAVmed获得180天的延期以恢复纳斯达克上市合规
2025-07-30 20:16
- PAVmed (NASDAQ:PAVM) has been granted a 180-day extension to regain compliance with the $1.00 minimum bid price requirement under the Nasdaq listing rule.
- The company now has until January 19, 2026 to meet the requirement.
- Source: Press Release
More on PAVmed, Lucid Diagnostics
- PAVmed Inc. (PAVM) Q1 2025 Earnings Call Transcript
- Lucid Diagnostics Inc. (LUCD) Q1 2025 Business Update Call Transcript
- Lucid nearing Medicare coverage for EsoGuard test, maintain at Buy: BTIG
- Lucid says meeting scheduled to determine Medicare coverage for cancer test
- Seeking Alpha’s Quant Rating on PAVmed
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
